Imlunestrant

{
  "id": "MLC-T-ONC-014378",
  "term": "Imlunestrant",
  "field": "Oncology and biomedicine",
  "definition": "An orally available selective estrogen receptor degrader (SERD), with potential antineoplastic activity. Upon oral administration, imlunestrant specifically targets and binds to the estrogen receptor (ER) and induces a conformational change that results in ER degradation. This prevents ER-mediated signaling and inhibits both the growth and survival of ER-expressing cancer cells.",
  "synonyms": [
    "SERD LY3484356"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/imlunestrant/"
}